在患有间歇性关节障碍的患者中,针对甲状腺封闭性疾病的内血管和混合干预
Levester Kirksey1, Khaled I Alnahhal1, Ahmed A Sorour1
1Department of Vascular Surgery, Heart Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, OH.
Annals of vascular surgery
|October 19, 2024
概括
对于复杂的风脉关闭性疾病 (AIOD) 的内血管治疗,包括或不包括常见的股骨内关节切除术 (CFE),对于间歇性关节障碍 (IC) 是安全有效的. 这种方法提供了持久的结果,证明了其在晚期疾病患者的使用.
科学领域:
- 血管外科 血管外科
- 血管内干预 血管内干预
- 周围动脉疾病 周围动脉疾病
背景情况:
- 间歇性音 (IC) 管理在不同动脉段之间有很大差异.
- 甲状腺闭塞病 (AIOD) 在治疗选择中提出了复杂的挑战.
研究的目的:
- 评估IC患者复杂AIOD内血管治疗的安全性,疗效和耐久性.
- 为了比较具有或没有常见的股骨内关节切除术 (CFE) 的内血管手术的结果.
主要方法:
- 在180名患者中对245个四肢进行了回顾性审查,这些患者在内血管方法 (2010-2020年) 中接受了AIOD治疗.
- 包括标准:IC的症状. 评估结果:并发症,通病率和免于重新干预.
- 亚组分析比较了仅内血管和混合内血管和CFE程序.
主要成果:
- 低并发症率:7.4%的受伤部位,7.9%的伤口并发症,0.82%的截肢.
- 优秀的通透率:1年 (94%),2年 (77%),5年 (58%) 主要;1年 (98%),2年 (91%),5年 (79%) 主要辅助.
- 使用CFE的混合方法显示出较低的发病率和出色的血管通透性,结果趋向于改善.
结论:
- 具有或没有CFE的复杂AIOD的内血管管理是IC患者的安全,有效和持久的选择.
- 这种方法支持高级AIOD的积极,以患者为中心的管理.
- 仔细的患者选择对于这种患者群体的最佳结果至关重要.
相关概念视频
Peripheral Artery Disease III: Interprofessional Care
2
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
2
Aneurysm III: Interprofessional Care
2
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
2
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
2
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
2
Peripheral Artery Disease V: Postoperative Nursing Management
3
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
3
Coronary Artery Disease V: Surgical Management
3
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
3
Atherosclerosis III: Management
1
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
1


